Researchers have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage.

Source: How melanoma can resist newly approved drug combo therapy


David Cottle

UBB Owner & Administrator